Im Cannabis Corp (IMCC) - Total Liabilities
Based on the latest financial reports, Im Cannabis Corp (IMCC) has total liabilities worth $35.35 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore IMCC cash flow conversion to assess how effectively this company generates cash.
Im Cannabis Corp - Total Liabilities Trend (2003–2025)
This chart illustrates how Im Cannabis Corp's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Im Cannabis Corp to evaluate the company's liquid asset resilience ratio.
Im Cannabis Corp Competitors by Total Liabilities
The table below lists competitors of Im Cannabis Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oldfields Holdings Ltd
AU:OLH
|
Australia | AU$26.16 Million |
|
Canzon Israel Ltd
TA:CNZN
|
Israel | ILA956.00K |
|
Proven Growth and Income Vct PLC
LSE:PGOO
|
UK | GBX272.00K |
|
Medesis Pharma SA
PA:ALMDP
|
France | €7.20 Million |
|
Seoul Food Ind Co Ltd
KO:004415
|
Korea | ₩46.52 Billion |
|
AGM Group Holdings Inc Class A
NASDAQ:AGMH
|
USA | $28.66 Million |
|
CJ Seafood Corp. Pfd. Series 1
KO:011155
|
Korea | ₩102.03 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Im Cannabis Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Im Cannabis Corp market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -41.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Im Cannabis Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Im Cannabis Corp (2003–2025)
The table below shows the annual total liabilities of Im Cannabis Corp from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $35.35 Million | -1.92% |
| 2024-12-31 | $36.04 Million | +2.65% |
| 2023-12-31 | $35.11 Million | -4.79% |
| 2022-12-31 | $36.88 Million | -55.27% |
| 2021-12-31 | $82.44 Million | +223.23% |
| 2020-12-31 | $25.51 Million | +433.04% |
| 2019-12-31 | $4.79 Million | +1801.45% |
| 2018-12-31 | $251.65K | -46.00% |
| 2017-12-31 | $465.99K | +7.83% |
| 2016-12-31 | $432.15K | +3.78% |
| 2015-12-31 | $416.40K | +7.70% |
| 2014-12-31 | $386.61K | +20.16% |
| 2013-12-31 | $321.74K | +28.44% |
| 2012-12-31 | $250.51K | -6.98% |
| 2011-12-31 | $269.30K | +265.48% |
| 2010-12-31 | $73.68K | -70.40% |
| 2009-12-31 | $248.93K | +380.31% |
| 2008-12-31 | $51.83K | -88.74% |
| 2007-12-31 | $460.11K | +102.02% |
| 2006-12-31 | $227.75K | -19.53% |
| 2005-12-31 | $283.04K | +116.60% |
| 2004-12-31 | $130.68K | +19.95% |
| 2003-12-31 | $108.94K | -- |
About Im Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv-Yafo, Israel.